Advertisement

Hated pharma CEO Martin Shkreli calls fraud charges ‘baseless’

In this Dec. 17, 2015 file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York. AP Photo/Craig Ruttle

NEW YORK – Bad-boy pharmaceutical company executive Martin Shkreli says fraud allegations against him are “baseless and without merit.”

Shkreli tweeted Saturday: “I am confident I will prevail.”

Story continues below advertisement

The 32-year-old former hedge fund manager pleaded not guilty Thursday in Brooklyn federal court and was released on $5 million bail.

Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.

Get weekly money news

Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

READ MORE: Martin Shkreli resigns as Turing CEO after securities fraud arrest

Shkreli was charged with securities fraud and conspiracy. Prosecutors say from 2009 to 2014, Shkreli lost some of his hedge fund investors’ money through bad trades, then looted a pharmaceutical company where he was CEO for $11 million to pay back his disgruntled clients.

READ MORE: Martin Shkreli arrested, but he still has the Wu-Tang album

Shkreli was already widely reviled because a drug company he founded raised the price of a life-saving drug from $13.50 to $750 per pill.

Sponsored content

AdChoices